rituximab,bendamustine,lenalidomide
teva
['rebel', 'bendamustine', 'hovon110,rebel ', 'lymsm']
congress | #ash22 presents data from the phase ii hovon110/rebel trial of r2 or r2 + bendamustine in pts with r/r #fl. both regimens demonstrated high orr and pet cmr rates. the results support ongoing r2 combination studies in fl. #lymsm #hematology 
A global education platform providing clinical updates on a range of lymphoma subtypes and chronic lymphocytic leukemia (#CLL) #lymsm